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The capacity to coordinate environmental sensing with initiation of cellular responses
underpins microbial survival and is crucial for virulence and stress responses in microbial
pathogens. Here we deﬁne circuitry that enables the fungal pathogen Candida albicans to
couple cell cycle dynamics with responses to cell wall stress induced by echinocandins,
a front-line class of antifungal drugs. We discover that the C. albicans transcription factor
Cas5 is crucial for proper cell cycle dynamics and responses to echinocandins, which inhibit
β-1,3-glucan synthesis. Cas5 has distinct transcriptional targets under basal and stress
conditions, is activated by the phosphatase Glc7, and can regulate the expression of target
genes in concert with the transcriptional regulators Swi4 and Swi6. Thus, we illuminate a
mechanism of transcriptional control that couples cell wall integrity with cell cycle regulation,
and uncover circuitry governing antifungal drug resistance.
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The fungal kingdom encompasses diverse species, includinga minority that have a devastating impact on humanhealth. One of the most pervasive fungal pathogens of
humans is Candida albicans1, 2, which is a commensal on the
skin and mucosal surfaces of up to 60% of healthy individuals3.
As an opportunist, C. albicans can exploit a decline in host
immunity or an imbalance in the host microbiome, leading to
diverse pathologies such as oral thrush, vaginal candidiasis,
or life-threatening bloodstream infections with mortality rates of
~40%4, 5. C. albicans thrives as a human pathogen in part due to
its ability to evade host immunity by switching between yeast and
ﬁlamentous morphologies, as well as due to its capacity to
withstand the hostile host environment by activating robust stress
responses6. The emerging paradigm is that C. albicans stress
response pathways are not only critical for adaptation to host
conditions, but they also enable fungal virulence and drug resis-
tance7–11.
The emergence of resistance to the limited arsenal of antifungal
drugs impedes the effective treatment of systemic infections12–14.
A poignant example is the evolution of resistance to the only new
class of antifungal to be approved in decades, the echino-
candins15, 16. Echinocandins block β-1,3-glucan biosynthesis in
the fungal cell wall via inhibition of the glucan synthase Fks1,
thereby compromising cell wall integrity. The most common
mechanism of echinocandin resistance involves mutations in the
drug target FKS117, 18; however, resistance phenotypes are also
modulated by cellular stress responses8, 9, 11. Targeting core hubs
in cellular circuitry that control responses to stress, such as the
molecular chaperone Hsp90 or protein phosphatase calcineurin,
has emerged as a powerful strategy to enhance antifungal activity
against diverse fungal pathogens8, 16. A challenge in targeting
Hsp90 or calcineurin in antifungal drug development is that they
are conserved and important regulators in the human host.
An expanded repertoire of potential targets is provided by
effectors downstream of these cellular regulators. C. albicans
mobilizes diverse stress response programs through the action of
transcription factors. For example, in response to cell membrane
and cell wall stress, the transcription factor Crz1 is activated by
calcineurin, leading to the induction of calcineurin-dependent
genes19, 20. Another example from the model yeast Saccharomyces
cerevisiae is the cell wall stress-dependent activation of the
transcription factor Rlm1 by the MAP kinase Mpk121. Although
Rlm1 is the main transcriptional regulator of cell wall stress
responses in S. cerevisiae, its function is not conserved in
C. albicans22. In C. albicans, the zinc ﬁnger transcription factor,
Cas5, serves as a key transcriptional regulator of responses to cell
wall stress22. Cas5 lacks an ortholog in S. cerevisiae and most
other eukaryotes, and the mechanism by which it is regulated
remains enigmatic.
Activation of stress responses can induce diverse physiological
changes, including modulation of cell cycle progression and
remodeling of cell wall architecture23–27. The most well char-
acterized stress response pathway involved in cell cycle regulation
is controlled by the MAP kinase Hog126. In response to osmotic
stress, Hog1 mediates a transient cell cycle arrest to enable cel-
lular adaptation26. Multiple stress response pathways coordinate
cell wall remodeling in response to environmental perturbations,
including heat shock27, osmotic stress28, and cell wall stress29.
However, little is known about whether cell cycle progression and
cell wall remodeling are coordinated in response to stress in
C. albicans, and whether there is a central signaling pathway that
integrates these fundamental aspects of cellular biology.
Here, we harness genome-wide approaches to elucidate the
mechanism by which Cas5 orchestrates transcriptional changes in
response to cell wall perturbation. We identify an unexpected
role for Cas5 in coupling cell cycle dynamics to cell wall stress
responses, and determine that Cas5 regulates distinct transcrip-
tional programs under basal and stress conditions. We discover
that Cas5 is activated by the type I protein phosphatase Glc7 in
response to cell wall stress, and it regulates cell wall homeostasis
in part through its interaction with Swi4-Swi6 cell cycle box-
binding factor (SBF) complex members, Swi4 and Swi6. Finally,
we describe a role for Cas5 in orchestrating nuclear division. Our
work provides insight into cellular reprogramming in response to
cell wall stress, and establishes regulatory circuitry that couples
stress response, cell cycle regulation, and drug resistance.
Results
Cas5 is a biologically responsive transcriptional regulator. Cas5
was originally identiﬁed in a genetic screen for transcription
factor mutants that are hypersensitive to the echinocandin
caspofungin, and microarray analysis implicated Cas5 in the
regulation of genes important for cell wall integrity in response
to cell wall stress22. However, the role of Cas5 under basal con-
ditions remained elusive. To further understand Cas5 function
under basal conditions, we sought to explore the impact of Cas5
on regulation of global transcriptional proﬁles in rich medium.
To do so, we used chromatin immunoprecipitation (ChIP) of
RNA polymerase II (PolII) coupled to sequencing (ChIP-Seq)
with a wild-type strain and cas5Δ/cas5Δ mutant. RNA PolII
occupancy has been found to serve as a more precise measure of
transcriptional regulation than steady state transcript levels, given
that transcript levels depend on RNA turnover in addition to
transcription factor activity and RNA PolII-mediated transcrip-
tion30. As RNA PolII recruitment corresponds to transcriptional
activity, an increase in RNA PolII occupancy indicates
upregulation of gene expression, whereas a decrease in RNA PolII
occupancy indicates downregulation30, 31. Further, strong corre-
lation in RNA PolII binding between our biological replicates
supported the reproducibility of this method (Supplementary
Fig. 1). We identiﬁed 329 genes that had increased RNA PolII
occupancy, and 275 genes that had reduced PolII occupancy in
the cas5Δ/cas5Δ mutant as compared with the wild-type strain
under standard growth conditions (Supplementary Data 1). To
identify the physiological roles of Cas5, we subjected these gene
sets to pathway analysis using Gene Ontology (GO). The sets that
had reduced RNA PolII occupancy upon deletion of CAS5 were
signiﬁcantly enriched in genes with functions in diverse processes,
including metabolic processes and interaction with host (Fig. 1a
and Supplementary Data 1). In contrast, the gene set that had
increased RNA PolII occupancy in a cas5Δ/cas5Δ mutant
was enriched in genes with functions associated with rRNA
processing, respiration, and amino acid biogenesis (Fig. 1a and
Supplementary Data 1). We also employed Kyoto Encyclopedia of
Genes and Genomes (KEGG) analysis as a secondary approach
to identify genes and pathways affected by deletion of CAS5.
Consistent with our GO term analysis, many genes with RNA
PolII-binding proﬁles that were affected by Cas5 were associated
with ribosome biogenesis and metabolic pathways (Fig. 1b and
Supplementary Data 1). KEGG analysis also identiﬁed a signature
of differentially bound genes with functions in meiosis, cell cycle,
and DNA replication (Fig. 1c and Supplementary Data 1).
Thus, Cas5 governs diverse biological responses under basal
conditions.
Next, we explored the impact of Cas5 on global responses to
cell wall stress. We mapped genome-wide RNA PolII occupancy
during caspofungin treatment in wild-type and cas5Δ/cas5Δ
strains. In a wild-type strain, 546 genes had distinct RNA PolII-
binding proﬁles in response to caspofungin treatment, with
increased binding for 294 genes and reduced binding for 252
genes (Supplementary Data 2). As expected, many genes with
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Fig. 1 Cas5 has a profound impact on RNA PolII binding at genes implicated in cell wall and cell cycle processes under both basal and cell wall stress
conditions. a Heat maps showing the genes with increased (red) and decreased (blue) RNA PolII binding in a cas5Δ/cas5Δ mutant relative to wildtype.
Enriched GO processes are indicated, and were clustered using the DAVID Gene Functional Classiﬁcation Tool. b Bar chart showing the number of genes
differentially bound by PolII (DBGs differentially bound genes), with increased binding in red and decreased binding in blue, in a cas5Δ/cas5Δ mutant
relative to wildtype based on their assigned KEGG pathways. KEGG pathways with four or more genes assigned are shown. c Bar chart showing the number
of genes differentially bound by PolII, with increased binding in red and decreased binding in blue, in a cas5Δ/cas5Δ mutant relative to wildtype belonging to
select KEGG pathways involved in cell cycle and related processes. d, e Bar charts showing the number of differentially bound genes involved in the
indicated physiological pathways upon caspofungin treatment, with increased binding in red and decreased binding in blue, in a wild-type strain in response
to caspofungin. KEGG pathways were grouped according to the ratio of genes with increased PolII binding to genes with decreased PolII binding in
response to caspofungin, with d enriched for genes with increased PolII binding and e enriched for genes with decreased PolII binding. KEGG pathways with
ﬁve or more genes assigned are shown. f Venn diagram depicting number of genes differentially bound by RNA PolII in response to caspofungin in the
wild-type reference (increased, green; decreased, yellow) and cas5Δ/cas5Δmutant (increased, red; decreased, blue) strains. See Supplementary Data 1–4 for
full data sets
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increased RNA PolII binding upon caspofungin exposure were
important for tolerating cell wall stress (Fig. 1d and Supplemen-
tary Data 2), whereas genes with reduced RNA PolII binding were
involved in diverse biological processes, including cell cycle
progression (Fig. 1e and Supplementary Data 2). Strikingly,
comparison of genes that were differentially bound in response to
caspofungin between the wild-type strain and the cas5Δ/cas5Δ
mutant, revealed that >60% of caspofungin-responsive genes
were dependent on Cas5. Speciﬁcally, 163 of the 294 genes with
increased PolII occupancy in response to caspofungin exposure
and 178 of the 252 genes with reduced occupancy were dependent
on Cas5 (Fig. 1f and Supplementary Data 2–4). These ﬁndings
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suggest that Cas5 has a profound impact on global transcriptional
responses to cell wall stress.
Finally, we focused on those genes with Cas5-dependent
differences in RNA PolII binding under basal and cell wall stress
conditions. Strikingly, only 28% of genes with Cas5-dependent
differences in RNA PolII binding were common to both
untreated and caspofungin treatment conditions (Fig. 2a and
Supplementary Data 1, 3 and 4). The Cas5-dependent genes
speciﬁc to each condition had different physiological functions
(Fig. 2c and Supplementary Data 4). Our analysis revealed a
major overlap of genes that had Cas5-dependent increased RNA
PolII occupancy under basal conditions with those that had
reduced RNA PolII occupancy in a wild-type strain in response to
caspofungin treatment (Fig. 2d and Supplementary Data 5),
suggesting that caspofungin impedes Cas5-mediated expression
of its basal-speciﬁc targets. Collectively, we identiﬁed hundreds of
new Cas5-dependent transcriptional events under basal and stress
conditions, implicating Cas5 in governing distinct transcriptional
programs in response to different environmental conditions.
Cas5 is a transcriptional regulator of cell wall homeostasis.
Given that Cas5 is known to regulate cell wall integrity22, we
sought to further evaluate the impact of Cas5 on cell wall
homeostasis. We observed that Cas5 has a profound impact on
RNA PolII binding to genes with cell wall functions; GO terms
from process ontology revealed that 23 of the 163 genes with
Cas5-dependent increases in RNA PolII binding in response to
caspofungin encode proteins involved in cell wall organization
and biogenesis (P-value 7.45e–06, Bonferroni Correction) (Sup-
plementary Data 3). Among these genes were WSC1 and WSC2,
which encode transmembrane sensors that respond to cell wall
perturbations, yet have not been previously linked to Cas5.
We conﬁrmed the induction of these transcripts in response to
caspofungin was dependent on Cas5 by quantitative RT-PCR
(qRT-PCR) (Fig. 3a). We next evaluated the impact of Cas5 on
tolerating cell wall stress in a wild-type strain and an
echinocandin-resistant mutant. We measured susceptibility
of a cas5Δ/cas5Δ mutant to two cell wall perturbing agents,
caspofungin and calcoﬂuor white. The cas5Δ/cas5Δ mutant was
hypersensitive to both cell wall stressors, and the hypersensitivity
phenotype was complemented by re-introduction of a wild-type
allele (Fig. 3b). Given that the most common mechanism of
resistance to echinocandins is mutations in the drug target gene,
FKS1, we tested whether Cas5 also enables Fks-dependent
caspofungin resistance. Homozygous deletion of CAS5 reduced
resistance of a strain carrying the Fks1F641S substitution, sug-
gesting Cas5 is a key regulator of target-mediated echinocandin
resistance (Fig. 3b). Thus, Cas5 regulates cell wall stability during
periods of cell wall stress, with a profound impact on drug
resistance.
Next, we assessed if Cas5 regulates the expression of genes
important for cell wall homeostasis in the absence of cell wall
stress. We found that 110 out of the 275 genes that have reduced
RNA PolII binding in the cas5Δ/cas5Δ mutant under basal
conditions were associated with cell membrane, cell wall, and cell
periphery GO components (Supplementary Data 1). Thus, we
predicted Cas5 enables cell wall stability in the absence of cell wall
stress, such that deletion of CAS5 would induce cell wall stress
under basal conditions. To determine if a cas5Δ/cas5Δ mutant is
intrinsically defective in cell wall architecture, we monitored
phosphorylation of the terminal cell wall integrity MAP kinase,
Mkc1, under basal conditions32. Compared with a wild-type
control, the cas5Δ/cas5Δ mutant had elevated levels of Mkc1
phosphorylation under basal conditions (Fig. 3c and Supplemen-
tary Fig. 2a). Moreover, expression of RLM1, a transcription
factor downstream of Mkc1, was upregulated in the cas5Δ/cas5Δ
mutant under basal conditions (Fig. 3d), suggesting strains
lacking Cas5 experience intrinsic cell wall stress. Our results
indicate Cas5 maintains cell wall homeostasis under basal
conditions and during cell wall stress.
Cas5 is a transcriptional regulator of cell cycle dynamics. We
observed an intriguing role of Cas5 on governing RNA PolII
binding at genes important for cell cycle, meiosis, and DNA
replication (Figs. 1c and 2c), suggesting Cas5 regulates cell cycle
dynamics under basal and cell wall stress conditions. If this were
the case, the expression pattern of cell cycle regulated genes
would be perturbed in the absence of Cas5. Using the Candida
cell cycle database33, we determined that 56 out of the 604 genes
that had Cas5-dependent RNA PolII binding under basal con-
ditions, were genes whose expression peaked during the cell cycle
(Supplementary Data 6). Of these, over 75% (43 out of 56) had
reduced RNA PolII binding in the cas5Δ/cas5Δ mutant as com-
pared with the wild-type strain (Fig. 4a and Supplementary
Data 6). Next, we analyzed the class of genes involved in cell cycle
that had reduced RNA PolII binding upon caspofungin treatment
(Fig. 1e). Among these genes were all six factors of the mini-
chromosome maintenance (MCM) complex (Fig. 4b), which has
important roles in the formation of the pre-replicative complex
(pre-RC) prior to DNA replication34. Reduced RNA PolII bind-
ing at genes encoding MCM complex components was dependent
on Cas5 (Fig. 4b). As expected, qRT-PCR conﬁrmed that reduced
expression of representative genes, MCM2 and MCM3, was also
dependent on Cas5 (Fig. 4c). Finally, we classiﬁed genes that were
differentially bound by RNA PolII in response to caspofungin
based on their peak expression throughout the cell cycle, once
again using the Candida cell cycle database33. In the wild-type
strain, genes with increased RNA PolII binding in response to
caspofungin were predominantly G1-speciﬁc, and those with
reduced RNA PolII binding were predominantly M phase-speciﬁc
Fig. 2 Cas5 regulatory network is rewired in response to caspofungin treatment. a, b Heat maps comparing Cas5-dependent genes with caspofungin-
regulated genes. a The left heat map shows the overlap of genes with Cas5-dependent increased RNA PolII binding with (+) and without (−) caspofungin
treatment. Cas5-dependent genes are indicated by a solid blue line. The right heat map indicates those genes with increased binding (red) and decreased
binding (blue) in a wild-type strain upon caspofungin treatment. b The left heat map shows the overlap of genes with Cas5-dependent reduced RNA PolII
binding with (+) and without (−) caspofungin treatment. Cas5-dependent genes are indicated by a solid red line. The right heat map indicates those genes
with increased (red) or decreased (blue) RNA PolII binding in a wild-type strain upon caspofungin treatment. c Bar graph showing the relative percentage of
Cas5-dependent genes speciﬁc to basal conditions (blue bars), speciﬁc to caspofungin treatment (red bars), or common to both conditions (white bars) in
the indicated KEGG pathways. The total number of genes belonging to each KEGG pathway are indicated. Only selected KEGG pathways are shown based
on number of genes enriched for PolII binding either under basal or caspofungin conditions. See Supplementary Data 4 for complete data set. d Venn
diagram depicting number of genes differentially bound in a cas5Δ/cas5Δ mutant relative to wildtype under basal conditions (increased, red; decreased,
blue) and genes responding to caspofungin treatment in a wild-type strain (increased, green; decreased, yellow). The 131 genes highlighted in red text
represent the substantial fraction of the genes with Cas5-dependent increase in RNA PolII binding under basal conditions that have reduced PolII binding in
response to caspofungin
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(Fig. 4d and Supplementary Data 6). Importantly, these trends
were less apparent in a mutant lacking Cas5 (Fig. 4d and Sup-
plementary Data 6). Overall, our results highlight the important
role of Cas5 in ensuring appropriate cell cycle dynamics under
basal conditions and in response to cell wall stress.
Cas5 is activated by dephosphorylation. Given our ﬁndings that
Cas5 governs cell cycle dynamics and cell wall stress responses,
we next explored the mechanisms by which it is regulated.
Initially, we monitored the subcellular localization of Cas5 by
indirect immunoﬂuorescence in a strain in which both alleles of
CAS5 were HA-tagged. The Cas5-HA protein was functional
and sufﬁcient to confer wild-type tolerance to caspofungin
(Supplementary Fig. 3a). Under basal conditions, Cas5 appeared
diffuse throughout the cytoplasm, however following treatment
with caspofungin, Cas5 translocated to the nucleus (Fig. 5a).
Owing to the moderate expression of Cas5 under its native
promoter, we employed a strain in which we could overexpress
Cas5 to facilitate its localization in the absence of stress.
Overexpression of HA-tagged Cas5 conﬁrmed that Cas5 was
mostly cytoplasmic, as observed when under its native promoter
(Fig. 5b). Overexpression also enabled us to observe a sub-
population of cells in which Cas5 was localized to the nucleus
even in the absence of cell wall stress (Fig. 5b). Next, we assessed
changes in Cas5 abundance in response to caspofungin. CAS5
transcript and protein levels were induced in response to cell
wall stress, as measured by qRT-PCR and western blot analysis
(Fig. 5c, d and Supplementary Fig. 2b). Thus, in response to cell
wall perturbation by caspofungin, Cas5 is induced and translo-
cates to the nucleus.
When monitoring Cas5 protein levels, we observed that the
Cas5 protein demonstrated a downward band shift when cells
were exposed to cell wall antagonists, indicative of a post-
translational modiﬁcation (Fig. 5e and Supplementary Fig. 2c).
To conﬁrm this shift was a consequence of cell wall stress,
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Fig. 3 Cas5 regulates cell wall stability under basal and cell wall stress conditions. a WSC1 and WSC2, transmembrane sensors that respond to cell wall
perturbation, require Cas5 for upregulation in response to caspofungin. The transcript level of WSC1 and WSC2 were monitored by qRT-PCR and
normalized to TEF1. Plotted are the log2 fold-changes in transcript levels upon caspofungin treatment relative to untreated conditions in both the wildtype
(black) and cas5Δ/cas5Δ mutant (gray). Error bars represent standard deviation (s.d.) from the mean of triplicate samples. Signiﬁcance was measured with
an unpaired t test in GraphPad Prism (**P< 0.01). b Cas5 is required for tolerance and resistance to cell wall stress. Caspofungin or calcoﬂuor white
susceptibility assays were conducted in YPD medium. Growth was measured by absorbance at 600 nm after 48 h at 30 °C. Optical densities were
averaged for duplicate measurements. Data was quantitatively displayed with color using Treeview (see color bar). c Deletion of CAS5 leads to the
activation of the cell wall integrity pathway in the absence of cell wall stress. A SN95 wild-type strain and a cas5Δ/cas5Δ mutant were left untreated (−) or
treated for 1 h with 125 ng/ml of caspofungin (+), as indicated. Phosphorylated Mkc1 was monitored by western blot and detected with α-p44/42 antibody.
Full blots are shown in Supplementary Fig. 2a. Cdc28 was detected with α-PSTAIRE antibody and used as a loading control. d RLM1, a transcription factor
downstream of Mkc1 in the cell wall integrity pathway, is induced in a cas5Δ/cas5Δ mutant in the absence of cell wall tress. The transcript level of RLM1
was monitored by qRT-PCR and normalized to TEF1. Differences in transcript level upon caspofungin treatment relative to untreated conditions are plotted.
Error bars represent s.d. from the mean of triplicate samples. Signiﬁcance was measured with an unpaired t test in GraphPad Prism (***P< 0.001)
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we employed a strain in which we could speciﬁcally inhibit the
kinase activity of the cell wall integrity regulator Pkc135. In this
strain, the only allele of PKC1 carries an M850G gatekeeper
mutation, rendering the kinase susceptible to inhibition by ATP
analog 1-naphthyl-PP1 (1-NA-PP1), without affecting its kinase
activity in the absence of the inhibitor35, 36. In the presence of
1-NA-PP1, the gatekeeper mutant was hypersensitive to caspo-
fungin, similar to a pkc1Δ/pkc1Δmutant (Supplementary Fig. 3b).
Inhibition of Pkc1 kinase activity induced Cas5 protein levels and
resulted in a downward mobility shift (Fig. 5f and Supplementary
Fig. 2d), similar to what was observed in a wild-type strain treated
with caspofungin (Fig. 5d). Given that a change in protein
phosphorylation is a common mechanism to regulate transcrip-
tion factor activity37, we assessed whether Cas5 was modiﬁed by
phosphorylation. We performed two-dimensional gel electro-
phoresis coupled to western blot analysis. In the absence of stress,
Cas5-HA resolved into a heterogeneous population of differen-
tially charged species (Fig. 5g). In response to caspofungin, Cas5
collapsed into a less electronegative species, consistent with
protein dephosphorylation. To conﬁrm that Cas5 was phos-
phorylated under basal conditions, we monitored Cas5 mobility
by western blot analysis following lambda phosphatase treatment.
Phosphatase treatment led to a faster migrating Cas5 band,
consistent with Cas5 being a phosphoprotein (Fig. 5h and
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Supplementary Fig. 2e). Finally, to determine if dephosphoryla-
tion of Cas5 is coupled to the activation of gene expression,
we monitored transcript levels of ECM331 and PGA13, two
Cas5-dependent caspofungin-responsive cell wall genes
(Supplementary Data 4)22. ECM331 and PGA13 were upregulated
in wild-type cells with the same caspofungin exposure required to
induce Cas5 dephosphorylation, and this upregulation was
partially blocked by deletion of CAS5 (Fig. 5i). Thus, Cas5 is
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regulated by dephosphorylation and governs the expression of
caspofungin-responsive cell wall genes in response to cell wall
stress.
A Cas5 serine residue is critical for caspofungin tolerance.
On the basis of our observations that Cas5 function is regulated
by phosphorylation, we hypothesized that dephosphorylation of
key residues is important for Cas5 activation. To map the
phosphorylation residues on Cas5 important for its activity, we
performed immunoprecipitation coupled to mass spectrometry
with HA-tagged Cas5. Phosphorylation was detected at serine
residues S462 and S476 (Supplementary Fig. 4a). To test whether
these serine residues along with two other adjacent residues,
S464 and S472, were functionally important for Cas5 function in
regulating cell wall integrity, we mutagenized all four serines to
either glutamic acid, to mimic a constitutively phosphorylated
state, or alanine, to mimic a constitutively unphosphorylated
state. The resulting mutants displayed wild-type tolerance
to caspofungin (Supplementary Fig. 4b), with no appreciable
difference in the band shift upon caspofungin treatment (Sup-
plementary Fig. 4c), suggesting that the sites identiﬁed by mass
spectrometry were not sufﬁcient to control Cas5 function.
To identify other potential Cas5 phosphorylation sites, we
analyzed its amino acid sequence using NetPhos and followed up
on S769, a highly conserved residue in one of the zinc ﬁnger
domains with a phosphorylation site-prediction score of 0.980
(Fig. 6a)38, 39. To assess the functional signiﬁcance of this residue,
we engineered strains in which one allele of CAS5 was deleted and
the other was replaced with a wild-type allele, the phosphomi-
metic S769E allele, or the phosphodeﬁcient S769A allele.
Introduction of the phosphomimetic S769E allele as the only
source of CAS5 phenocopied homozygous deletion of CAS5 in
terms of hypersensitivity to caspofungin, whereas introduction of
the phosphodeﬁcient S769A allele conferred a wild-type pheno-
type (Fig. 6b). Consistent with our hypothesis, the S769E
mutation blocked the upregulation of ECM331 and PGA13 in
response to caspofungin, whereas the S769A mutation did not
(Fig. 6c). Notably, these mutations did not affect Cas5 induction
or dephosphorylation in response to caspofungin (Fig. 6d and
Supplementary Fig. 2f), suggesting that the S769E substitution
does not affect the capacity of Cas5 to sense cell wall stress,
and that additional phosphorylation sites remain to be identiﬁed.
Our data supports a model in which Cas5 is activated by
dephosphorylation in response to cell wall stress.
Glc7 dephosphorylates Cas5 in response to cell wall stress. To
identify the phosphatase that regulates Cas5 activity, we leveraged
insights from the model yeast S. cerevisiae. A BLASTp search of
the C. albicans Cas5 protein sequence against the S. cerevisiae
protein database identiﬁed Mig1, Msn4, Mig2, and Msn2 as
proteins with similar sequences40. Mig1, Msn4, and Msn2 are
dephosphorylated by the type I protein phosphatase Glc741, 42. As
Glc7 inﬂuences cell wall maintenance in S. cerevisiae43, we
hypothesized that Glc7 was required for activating cell wall stress
responses in C. albicans. We engineered a strain in which we
could transcriptionally repress GLC7 by deleting one allele and
replacing the native promoter of the remaining allele with a
tetracycline-repressible promoter. We conﬁrmed that GLC7
expression was repressed in the presence of the tetracycline
analog doxycycline by qRT-PCR (Supplementary Fig. 5a).
Depletion of GLC7 with doxycycline conferred hypersensitivity to
caspofungin (Fig. 7a), conﬁrming Glc7 is important for tolerating
cell wall stress in C. albicans. Next, we examined the effect of
GLC7 depletion on Cas5 expression and function. Doxycycline-
mediated transcriptional repression of GLC7 did not block
upregulation of Cas5 in response to caspofungin (Fig. 7b and
Supplementary Fig. 2g), but did block the downward band shift
associated with dephosphorylation, as was evident with equiva-
lent Cas5 levels loaded per sample (Fig. 7c and Supplementary
Fig. 2h). Depletion of GLC7 also blocked the upregulation of
Cas5-dependent caspofungin-responsive genes, ECM331 and
PGA13 (Fig. 7d). Thus, Glc7 activates Cas5 by dephosphorylation
in response to cell wall stress, thereby enabling transcriptional
upregulation of cell wall genes.
Cas5 governs cell wall stress responses with Swi4/Swi6. To
identify physical interactors of Cas5, we leveraged the results
from our immunoprecipitation coupled to mass spectrometry
analysis (Supplementary Data 7). The only interaction that passed
a stringent statistical analysis using Signiﬁcance Analysis of
Interactome (SAINT)44 with a probability threshold of 0.9 was
Swi4 (Supplementary Data 7), which interacts with Swi6 to form
the SBF complex in S. cerevisiae45. To validate the interaction
between Cas5 and the SBF complex, we individually tandem
afﬁnity puriﬁcation (TAP) tagged Swi4 or Swi6 at the C terminus
in a strain harboring Cas5-HA to enable co-immunoprecipitation
analysis. The Swi4-TAP and Swi6-TAP proteins were functional
and sufﬁcient to mediate wild-type tolerance to caspofungin
(Supplementary Fig. 5b). Immunoprecipitation of Cas5 with
anti-HA agarose co-puriﬁed both Swi4 and Swi6 (Fig. 8a and
Supplementary Fig. 6), verifying these proteins physically interact.
To determine whether the SBF complex has a role in cell wall
stress responses in C. albicans, we monitored the expression of
ECM331 and PGA13 in mutants lacking Swi4, Swi6, or Cas5. In
all three mutants, upregulation of these cell wall genes in response
to caspofungin was blocked (Fig. 8b). However, strains lacking
Swi4 or Swi6 displayed intermediate caspofungin susceptibility
phenotypes relative to a wild-type strain and a CAS5 homozygous
deletion mutant (Fig. 8c). Altogether, our results suggest that
Cas5 regulates transcriptional responses to cell wall stress in part
through the SBF complex and in part through an independent
mechanism.
Cas5 governs cell cycle dynamics independent of Swi4/Swi6.
Since our RNA PolII ChIP-Seq data implicated Cas5 in proper
cell cycle dynamics and DNA replication (Figs. 1c and 4), we
wanted to further investigate the impact of Cas5 on nuclear
division. We monitored the number of nuclei per cell in wildtype
and cas5Δ/cas5Δ strains. Cells were stained with DAPI for DNA
content and calcoﬂuor white for chitin (Fig. 9a and Supplemen-
tary Fig. 7a). During log phase, ~40% of cells lacking Cas5 were
multinucleated, an indication of uncontrolled DNA replication or
a defect in cytokinesis (Fig. 9b). Given that Swi4 and Swi6 phy-
sically interact with Cas5 (Fig. 8a) and that the SBF complex
regulates the G1/S phase progression in S. cerevisiae and
C. albicans46, 47, we also investigated their impact on nuclear
division. Strikingly, <10% of mutant cells lacking either Swi4 or
Swi6 showed a multinucleated phenotype, suggesting that the SBF
complex has a minor role in ensuring proper nuclear division in
C. albicans (Fig. 9a, b). We further investigated the defective
nuclear division associated with loss of Cas5 by time-lapsed
ﬂuorescence microscopy. To monitor DNA content, we RFP-
tagged histone H4, encoded by HHF1; to monitor mitotic spindle
positioning, we GFP-tagged the Dam1 complex subunit DAD2
(Fig. 9c, d). We observed multiple nuclei dividing simultaneously
in a single cell in a cas5Δ/cas5Δ mutant (Fig. 9d and
Supplementary Fig. 7b). Importantly, each nucleus had at least
one spindle pole body, suggesting that the accumulation of nuclei
was due to nuclear division and not spontaneous nuclear frag-
mentation (Fig. 9d and Supplementary Fig. 7b).
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-00547-y ARTICLE
NATURE COMMUNICATIONS |8:  499 |DOI: 10.1038/s41467-017-00547-y |www.nature.com/naturecommunications 9
Next, we assessed the ploidy of the cas5Δ/cas5Δ mutant
compared with a wild-type control by ﬂow cytometry. During log
phase growth in the absence of external stress, wild-type cells
exhibited two distinct peaks at 2C and 4C (representing the
G1- and G2-phases of the cell cycle, respectively), whereas the
cas5Δ/cas5Δ mutant exhibited ﬁve distinct peaks at 2C, 4C, 6C,
8C, and 12C (Fig. 9e and Supplementary Fig. 7c). Notably, peaks
at 1C and 3C were absent, indicating that the nuclei were not
haploidizing, mating, or undergoing reductional division. Instead,
these data suggest multiple rounds of DNA replication were
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occurring in the same cell, causing ploidy level increases similar
to what is observed when C. albicans is exposed to ﬂuconazole48.
Finally, to determine whether the dephosphorylated form of
Cas5 was required for controlled DNA replication, we quantiﬁed
the number of nuclei per cell in the phosphomutants. The CAS5
mutant carrying the phosphomimetic S769E substitution phe-
nocopied the cell cycle defects observed in the CAS5 homozygous
deletion mutant, whereas the mutant carrying phosphodeﬁcient
S769A substitution was indistinguishable from the wildtype
(Fig. 9f). Thus, our results support a novel role for the
dephosphorylated form of Cas5 in regulating nuclear division
that is largely independent of the SBF complex.
Discussion
The capacity to coordinate cell cycle progression with stress
responses is crucial for cellular survival to give cells time to
recover from a myriad of environmental perturbations, including
cell wall stress49. In the present work, we uncovered a dual role
for the transcription factor Cas5 in mediating cell cycle dynamics
and cell wall stress responses in C. albicans (Fig. 10). We
discovered that RNA PolII binding to many genes important for
cell wall biosynthesis and DNA replication is dependent on Cas5
under basal conditions (Fig. 1). We also found Cas5 regulates the
expression of a distinct set of cell wall and cell cycle genes in
response to cell wall stress (Fig. 2). We established Cas5 function
is regulated by the protein phosphatase Glc7 (Fig. 7), and Cas5
functions in concert with Swi4 and Swi6 to regulate cell wall
homeostasis (Fig. 8). Our ﬁndings implicate Cas5 at the core of a
novel mechanism by which cell cycle and cell wall integrity are
coordinately regulated.
The coordination of sensing and responding to cell wall stress
is crucial for fungi, and precise temporal control of cell wall stress
response regulators underpins the rapid mobilization of signaling
cascades that govern cellular integrity. We demonstrated that
Cas5 not only becomes activated in response to cell wall stress but
it also maintains cell wall stability under basal conditions (Figs. 3
and 5). Although Cas5 is not broadly conserved in the fungal
kingdom, its activation is regulated by a conserved protein
phosphatase, Glc7, which has 91% protein identity to the
S. cerevisiae ortholog. In S. cerevisiae, temperature sensitive glc7
mutants exhibit sorbitol-remediable lysis defects at the restrictive
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temperature, due to impaired cell wall integrity43. We demon-
strated Glc7 is required for cell wall maintenance in C. albicans
(Fig. 7). Glc7 substrates in S. cerevisiae include three proteins with
sequence similarity to Cas5: Mig1, Msn2, and Msn4. Msn2 and
Msn4 are transcription factors that are required for general stress
response in S. cerevisiae, but not in C. albicans50, 51. This high-
lights a divergence in signal transduction cascades required to
respond to environmental stressors, and suggests that Cas5 may
be the central downstream effector of Glc7 that modulates stress
responses in C. albicans. Consistent with this possibility, Cas5
controls responses not only to cell wall stress, but also to cell
membrane stress exerted by the azole antifungal drugs52.
In yeast, cell wall stress originates not only through environ-
mental perturbations but also through normal physiological
changes that are coupled to cell cycle progression, as cell wall
remodeling and biosynthesis are required to enable the emer-
gence of the growing daughter bud. In S. cerevisiae cell membrane
perturbation triggers cell cycle arrest via degradation of Cdc6, a
component of the pre-RC53. This is required for cell survival as
continued cell cycle progression in the presence of plasma
membrane damage induces plasma membrane rupture and cell
lysis, leading to cell death53. We found that CDC6 and genes
encoding members of the MCM complex that participate in the
pre-RC are transcriptionally repressed in response to caspofungin
in a Cas5-dependent manner (Fig. 4). To our knowledge, this is
the ﬁrst mechanistic insight into the signaling events that couple
cell wall stress with cell cycle arrest in C. albicans, and likely
enables the cell to respond to environmental stress without suc-
cumbing to cell death. In S. cerevisiae, cell cycle genes are regu-
lated by transcriptional complexes composed of Swi4 and Swi6,
including the SBF complex, which is involved in budding and
membrane/cell-wall biosynthesis54. We observed that impairment
of Cas5 function manifested in more severe misregulation of
nuclear division than deletion of SWI4 or SWI6 (Fig. 9), sug-
gesting Cas5 regulates nuclear division largely independent of the
SBF complex.
Targeting regulators of cellular circuitry that are crucial for
cellular stress responses may provide a powerful strategy for
antifungal drug development. This strategy opens up the oppor-
tunity for combining stress response inhibitors with current
antifungals for treatment of fungal infections. Promising exam-
ples of this approach include targeting the molecular chaperone
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Hsp90 or its downstream effector calcineurin, which are both
required for drug resistance and virulence of diverse fungal
pathogens8, 55. Given that both of these regulators are highly
conserved in humans and have essential functions in mobilizing
immune responses, the challenge in exploiting the therapeutic
utility of these targets for antifungal therapies hinges on the
development of fungal-selective inhibitors56. Our work further
supported the role of Cas5 in governing echinocandin tolerance
and established that Cas5 enables echinocandin resistance in a
strain harboring a mutation in the drug target gene FKS1
(Fig. 3b). As Cas5 lacks an identiﬁable ortholog in humans22,
but is required for drug resistance (Fig. 3b) and virulence in
C. albicans10, 57, it provides an attractive target for antifungal
drug development. There is growing support for the feasibility of
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chemical modulation of transcription factors based on blocking
transcription factor dimerization, DNA binding, or the interac-
tion with regulatory proteins58, 59. Elucidating mechanisms that
enable remodeling of transcriptional programs that control stress
response and virulence traits provides opportunities to expand
the antimicrobial target space in this era of antimicrobial
resistance.
Methods
Strains and reagents. All C. albicans strains were archived in 25% glycerol and
stored at −80 °C. Strains were grown in YPD (1% yeast extract, 2% bactopeptone,
and 2% glucose) at 30 °C unless otherwise speciﬁed. For solid media, 2% agar was
added. Strains were constructed according to standard protocols. Strains used
in this study are listed in Supplementary Table 1. Caspofungin was generously
provided by Terry Roemer (Department of Infectious Diseases, Merck Research
Laboratories) and was diluted to a 100 µg/ml stock, and used at a ﬁnal con-
centration of 125 ng/ml. Doxycycline (DOX, BD Biosciences #631311) was
formulated in a 20 mg/ml stock in water and used at a ﬁnal concentration of
0.02 µg/ml or 1 µg/ml, as speciﬁed.
Strain construction. CaLC2034: To generate a CAS5 heterozygous deletion
mutant, the NAT ﬂipper cassette (pLC49)60 was PCR ampliﬁed using primers
oLC2017 and oLC2018 (4366 bp) and transformed into CaLC239 (SN95).
NAT-resistant transformants were PCR tested with oLC275 in combination with
oLC2034 for upstream integration and oLC274 in combination with oLC2035 for
downstream integration. The SAP2 promoter was induced to drive expression of
FLP recombinase to excise the NAT ﬂipper cassette.
CaLC2056: To generate a CAS5 homozygous deletion mutant, the NAT ﬂipper
cassette (pLC49)60 was PCR ampliﬁed as described for CaLC2034 and transformed
into CaLC2034. NAT-resistant transformants were PCR tested for correct
integration of the cassette as described for CaLC2034. The presence of deleted allele
was veriﬁed by ampliﬁcation with primer pairs oLC2034 in combination with
oLC2035, and absence of wild-type allele was veriﬁed by ampliﬁcation with primer
pairs oLC2047 in combination with oLC2048. The SAP2 promoter was induced to
drive expression of FLP recombinase to excise the NAT ﬂipper cassette.
CaLC3908/CaLC3909: To generate a CAS5 heterozygous deletion mutant in a
strain carrying the FKS1F641S mutation, the NAT ﬂipper cassette (pLC49)60 was
PCR ampliﬁed as described for CaLC2034 and transformed into CaLC2087 (SN95
FKS1F641S/FKS1). Correct upstream and downstream integration at the CAS5 locus
was veriﬁed as described for CaLC2034. The SAP2 promoter was induced to drive
expression of FLP recombinase to excise the NAT ﬂipper cassette. To generate a
CAS5 homozygous deletion mutant, the NAT ﬂipper cassette (pLC49)60 was again
PCR ampliﬁed and transformed into the SN95 FKS1F641S/FKS1 CAS5/cas5::FRT
strain. Correct upstream and downstream integration at the CAS5 locus was
veriﬁed as described for CaLC2034. The absence of a wild-type allele was
conﬁrmed with oLC2034 in combination with oLC2164. The SAP2 promoter was
induced to drive expression of FLP recombinase to excise the NAT ﬂipper cassette.
CaLC3378: To C terminally HA tag CAS5 in a mutant carrying the PKC1M850G
mutation, the CAS5-HA-HIS cassette was released from pLC790 with ApaI and
transformed into SN95 PKC1M850G/PKC1. Proper integration at the CAS5 locus
was veriﬁed by ampliﬁcation using primer pairs oLC2163 in combination with
oLC2029 and oLC2164 in combination with oLC1645. Expression of HA-tagged
Cas5 was veriﬁed by western blot.
CaLC3859: To regulate the expression of CAS5, the tetracycline-repressible
transactivator, the tetO promoter, and the NAT ﬂipper cassette were PCR ampliﬁed
from pLC60561 using primers oLC2088 in combination with oLC2089. The PCR
ampliﬁed product was transformed into CaLC2034. Correct upstream and
downstream integration at the CAS5 locus was veriﬁed by amplifying across both
junctions using primer pairs oLC2034 in combination with oLC534 and oLC300 in
combination with oLC2145. The absence of a wildtype CAS5 promoter was veriﬁed
with oLC2034 in combination with oLC2035. To C terminally HA tag CAS5, the
CAS5-HA-HIS1 cassette was released from pLC818 with SacII and transformed
into the tetO-CAS5/cas5Δ. Correct upstream integration at the C terminus of CAS5
was veriﬁed by amplifying across the junction using primer pair oLC2163 in
combination with oLC2164. Expression of HA-tagged Cas5 was veriﬁed by
western blot.
CaLC3113: To C terminally HA tag CAS5 in a mutant heterozygous for CAS5,
the HA-HIS1 cassette was PCR ampliﬁed from pLC57562 using primers oLC2161
in combination with oLC2162 and transformed into CaLC2034. Transformants
prototrophic for histidine were PCR tested with C2163 in combination with
oLC2029 for upstream integration and oLC2164 in combination with oLC1645 for
downstream integration.
CaLC3151: To C terminally HA tag CAS5 in a mutant heterozygous for CAS5,
the CAS5-HA-HIS1 cassette was released from pLC790 with ApaI and transformed
into CaLC2034. Transformants prototrophic for histidine were PCR tested with
oLC2163 in combination with oLC2029 for upstream integration and oLC2164 in
combination with oLC1645 for downstream integration. This strain shares the
same genotype as CaLC3113 but was generated as a control for strains made using
plasmid pLC790 as the backbone, such pLC791 and pLC800.
CaLC4285: To C terminally HA tag CAS5, the HA-ARG4 cassette was PCR
ampliﬁed from pLC57662 using primers oLC2161 in combination with oLC2162
and transformed into CaLC1900. Correct integration at the C terminus of CAS5
was veriﬁed by using primer pair oLC2163 in combination with oLC2164.
CaLC2213: To C terminally HA tag CAS5 in SN95, the HA-HIS1 cassette was
PCR ampliﬁed from pLC57562 using primers oLC2161 in combination with
oLC2162 and transformed into CaLC239 (SN95). Transformants prototrophic for
histidine were PCR tested for correct integration of the cassette with oLC2163 in
combination with oLC2029 and oLC2164 in combination with oLC1645.
CaLC3044: To C terminally HA tag the both alleles of CAS5, the HA-ARG4
cassette was PCR ampliﬁed from pLC57662 as described for CaLC4285 and
transformed into CaLC2213. Transformants prototrophic for both histidine and
arginine were PCR tested for correct integration of the cassette as described for
CaLC4285.
CaLC3209: To introduce a mutant allele of CAS5 carrying the S769E mutation,
the CAS5S769E-HA-HIS1 cassette was released from pLC791 with ApaI and
transformed into CaLC2034. Transformants prototrophic for histidine were PCR
tested for integration of the cassette with oLC3052 in combination with oLC2029
and oLC2164 in combination with oLC1645. The absence of a wildtype CAS5 allele
was veriﬁed with oLC3052 in combination with oLC2164. The S769E mutation was
sequence veriﬁed with oLC2029.
CaLC3189: To introduce a mutant allele of CAS5 carrying the S769A mutation,
the CAS5S769A-HA-HIS1cassette was released from pLC800 with ApaI and
transformed into CaLC2034. Transformants prototrophic for histidine were PCR
tested for integration of the cassette as described for CaLC3209. The S769A
mutation was sequence veriﬁed with oLC2029.
CaLC4036: To generate a SWI4 homozygous deletion mutant, the NAT ﬂipper
cassette (pLC49)60 was PCR ampliﬁed using primers oLC3472 in combination with
oLC3473 and transformed into CaLC239 (SN95). NAT-resistant transformants
were PCR tested with oLC275 in combination with oLC3474 and oLC274 in
combination with oLC3427. The SAP2 promoter was induced to drive expression
of FLP recombinase to excise the NAT ﬂipper cassette. Once again, the NAT
ﬂipper cassette (pLC49)60 was PCR ampliﬁed using primers oLC3472 in
combination with oLC3473 and transformed into SWI4/swi4::FRT. NAT-resistant
transformants were PCR tested as described above. The absence of a wild-type
allele was veriﬁed with oLC3426 in combination with oLC3427, and the presence of
deleted allele was veriﬁed by oLC3473 in combination with oLC3427. The SAP2
promoter was induced to drive expression of FLP recombinase to excise the NAT
ﬂipper cassette.
CaLC4330: To generate a SWI6 homozygous deletion mutant, the NAT ﬂipper
cassette (pLC49)60 was PCR ampliﬁed using primers oLC3641 in combination with
oLC3642 and transformed into CaLC239 (SN95). NAT-resistant transformants
were PCR tested with oLC275 in combination with oLC3645 and oLC274 in
combination with oLC3654. The SAP2 promoter was induced to drive expression
of FLP recombinase to excise the NAT ﬂipper cassette. Once again, the NAT ﬂipper
cassette (pLC49)60 was PCR ampliﬁed using primers oLC3641 in combination with
oLC3642 and transformed into SWI6/swi6::FRT. NAT-resistant transformants were
PCR tested as described above. The absence of a wild-type allele and the presence
of the deleted allele was veriﬁed with oLC3645 in combination with oLC3431. The
SAP2 promoter was induced to drive expression of FLP recombinase to excise the
NAT ﬂipper cassette.
CaLC3391: To C terminally TAP tag Swi4, the TAP-ARG4 cassette was PCR
ampliﬁed from pLC57362 using primers oLC3424 in combination with oLC3425
and transformed into CaLC239. Transformants prototrophic for arginine were
PCR tested with oLC3426 in combination with oLC1593 and oLC1594 in
combination with oLC3427.
CaLC3393: To C terminally TAP tag Swi6, the TAP-ARG4 cassette was PCR
ampliﬁed from pLC57362 using primers oLC3428 in combination with oLC3429
and transformed into CaLC239. Transformants prototrophic for arginine were
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Fig. 10 Model for Cas5-mediated coupling of cell cycle progression to cell
wall stress response. Cas5 is dephosphorylated by the protein phosphatase
Glc7 in response to cell wall stress. Once dephosphorylated, it can
translocate to the nucleus to govern the expression of a myriad of genes,
including those important for cell cycle regulation and cell wall stress
response. Cas5 regulates changes in gene expression through both
Swi4/Swi6-dependent and independent mechanisms
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PCR tested with oLC3430 in combination with oLC1593 and oLC1594 in
combination with oLC3431.
CaLC3395: To C terminally TAP tag Swi4 in a strain with HA-tagged Cas5, the
TAP-ARG4 cassette was PCR ampliﬁed from pLC57362 as described for CaLC3391
and transformed into CaLC3151. Transformants prototrophic for arginine and
histidine were PCR tested as described for CaLC3391.
CaLC3398: To C terminally TAP tag Swi6 in a strain with HA-tagged Cas5, the
TAP-ARG4 cassette was PCR ampliﬁed from pLC57362 as described for CaLC3393
and transformed into CaLC3151. Transformants prototrophic for arginine and
histidine were PCR tested as described for CaLC3393.
CaLC3932: To generate a GLC7 heterozygous deletion mutant, the NAT ﬂipper
cassette (pLC49)60 was PCR ampliﬁed using primers oLC3490 in combination with
oLC3491 and transformed into CaLC239 (SN95). NAT-resistant transformants
were PCR tested with oLC275 in combination with oLC3558 and oLC274 in
combination with oLC3561. The SAP2 promoter was induced to drive expression
of FLP recombinase to excise the NAT ﬂipper cassette. To regulate the expression
of GLC7, the tetracycline-repressible transactivator, the tetO promoter, and the
NAT ﬂipper cassette were PCR ampliﬁed from pLC60561 using primers oLC3793
in combination with oLC3492 and transformed into GLC7/glc7::FRT. NAT-
resistant transformants were PCR tested with oLC3794 in combination with
oLC534 and oLC274 in combination with oLC3495. The absence of a wildtype
GLC7 promoter was veriﬁed with oLC3794 in combination with oLC3495, and the
presence of a deleted allele was veriﬁed with oLC3794 in combination with
oLC3494. The SAP2 promoter was induced to drive expression of FLP recombinase
to excise the NAT ﬂipper cassette.
CaLC3952: To C terminally HA tag CAS5 in the GLC7 repressible strain, the
HA-HIS1 cassette was PCR ampliﬁed from pLC57562 using primers oLC2161 in
combination with oLC2162 and transformed into CaLC3932. Transformants
prototrophic for histidine were PCR tested with oLC2163 in combination with
oLC2164.
CaLC3693/CaLC3694/CaLC3695: To introduce a mutant allele of CAS5
carrying S462E, S464E, S472E, and S476E mutations, the CAS5SS462E/S464E/S472E/
S476E-HA-HIS1 cassette was released from pLC857 with SacII and transformed into
CaLC2034. Transformants prototrophic for histidine were PCR tested with
oLC3052 in combination with oLC2029 and oLC2164 in combination with
oLC1645. The absence of an untagged wild type CAS5 allele was veriﬁed with
oLC3052 in combination with oLC2164. The S462A/S464A/S472A/S476A
mutations were sequence veriﬁed with oLC3371.
CaLC3672/CaLC3673: To introduce a mutant allele of CAS5 carrying S462A,
S464A, S472A, and S476A mutations, the CAS5S462A/S464A/S472A/S476A-HA-HIS1
cassette was released from pLC858 with SacII and transformed into CaLC2034.
Transformants prototrophic for histidine were PCR tested as described for
CaLC3693. The absence of an untagged wildtype CAS5 allele was veriﬁed with
oLC3052 in combination with oLC2164. The S462A/S464A/S472A/S476A
mutations were sequence veriﬁed with oLC3371.
CaLC4471: To C terminally TAP tag Swi4 in a mutant heterozygous for SWI4,
the TAP-ARG4 cassette was PCR ampliﬁed from pLC57362 using primers oLC3424
in combination with oLC3425 and transformed into CaLC3151. Transformants
prototrophic for arginine were PCR tested with oLC3426 in combination with
oLC3427.
CaLC4499: To C terminally TAP tag Swi6 in a mutant heterozygous for SWI6,
the TAP-ARG4 cassette was PCR ampliﬁed from pLC57362 using primers oLC3428
in combination with oLC3429 and transformed into SWI6/swi6::FRT.
Transformants prototrophic for arginine were PCR tested with oLC3430 in
combination with oLC1593 and oLC3430 in combination with oLC3431.
CaLC4705: To C terminally RFP tag Hhf1 in SN95, the RFP-NAT cassette was
PCR ampliﬁed from pLC447 using primers oLC4752 in combination with oLC4753
and transformed into CaLC239. Correct integration at the C terminus of HHF1 was
veriﬁed by amplifying across both junctions using primer pairs oLC4417 in
combination with oLC4754 and oLC274 in combination with oLC4755. To C
terminally GFP tag Dad2, the GFP-HIS cassette was PCR ampliﬁed from pLC38363
using primers oLC4748 in combination with oLC4749 and transformed into
HHF1-RFP/HHF1. Correct integration at the C terminus of DAD2 was veriﬁed by
amplifying across both junctions using primer pairs oLC600 in combination with
oLC4750 and oLC1645 in combination with oLC4751.
CaLC4707: To C terminally RFP tag Hhf1 in a cas5Δ/cas5Δ mutant, the RFP-
NAT cassette was PCR ampliﬁed from pLC447 as described for CaLC4705 and
transformed into CaLC2056. Correct integration at the C terminus of HHF1 was
veriﬁed as described for CaLC4705. To C terminally GFP tag Dad2, the GFP-HIS
cassette was PCR ampliﬁed from pLC38363 as described for CaLC4705 and
transformed into cas5Δ/cas5Δ HHF1-RFP/HHF1. Correct integration at the C
terminus of DAD2 was veriﬁed by as described for CaLC4705.
Plasmid construction. Cloning procedures were performed following standard
protocols. Plasmids used in this study are listed in Supplementary Table 2. The
absence of nonsynonymous mutations in plasmids was veriﬁed by sequencing.
Primers used in this study are listed in Supplementary Table 3. Plasmid con-
struction is described in detail below.
pLC447: This is a construct to tag proteins with RFP at the C terminus.
CaCherry/RFP was PCR ampliﬁed from pLC43564 with oLC841 in combination
with oLC842 and digested with BsrGI. This was cloned into pLC389 at BsrGI.
Directionality of the insert was veriﬁed by PCR with pLC849 in combination with
oLC842. The construct was sequence veriﬁed with oLC849 and oLC842.
pLC790: This is a construct to C terminally HA-tag Cas5 in C. albicans. The
CAS5 DNA-binding domain, HA, and HIS marker were ampliﬁed from CaLC3113
genomic DNA with primers oLC3092 in combination with oLC3052 and cloned
into pLC49 at the ApaI site. The ligation mixture was transformed into TOP10
cells. Cells were plated on LB + Amp +NAT. Correct integration of the cassette in
pLC49 was sequence veriﬁed with oLC2029. This construct can be liberated by
digestion with ApaI and transformed into C. albicans.
pLC791: This plasmid is based on pLC790 but harbors a phosphomimetic
mutation in CAS5 (S769E). This mutation was introduced by site-directed
mutagenesis with primers oLC2986 and oLC2987. The clone was sequence veriﬁed
with oLC2029. This construct can be liberated by digestion with ApaI and
transformed into C. albicans.
pLC800: This plasmid is based on pLC790 but harbors a phosphomimetic
mutation in CAS5 (S772E). This mutation was introduced by site-directed
mutagenesis with primers oLC2990 and oLC2991. The plasmid was sequence
veriﬁed with oLC2029. This construct can be liberated by digestion with ApaI and
transformed into C. albicans.
pLC818: This is a construct to C terminally HA-tag Cas5 in C. albicans. The
CAS5 ORF, HA, and HIS1 were ampliﬁed from CaLC3113 genomic DNA with
primers oLC3365 in combination with oLC3366 and cloned into pLC49 at the SacII
site. The ligation mixture was transformed into TOP10 cells. Cells were plated on
LB + Amp + NAT. Correct integration of the cassette in pLC49 was sequence
veriﬁed with oLC2029, oLC244, and oLC3371. This construct can be liberated by
digestion with SacII and transformed into C. albicans.
pLC828: This plasmid is based on pLC818 but harbors a phosphomimetic
mutation in CAS5 (S472E/S476E). This mutation was introduced by site-directed
mutagenesis with primers oLC3410 and oLC3411. The plasmid was sequence
veriﬁed with oLC3371. This construct can be liberated by digestion with SacII and
transformed into C. albicans.
pLC857: This plasmid is based on pLC828 but harbors additional
phosphomimetic mutations in CAS5 (S462E/S464E). This mutation was introduced
by site-directed mutagenesis with primers oLC3416 and oLC3417. The plasmid was
sequence veriﬁed with oLC3371. This construct can be liberated by digestion with
SacII and transformed into C. albicans.
pLC833: This plasmid is based on pLC818 but harbors a phosphodeﬁcient
mutation in CAS5 (S472A/S476A). This mutation was introduced by site-directed
mutagenesis with primers oLC3412 and oLC3413. The clone was sequence veriﬁed
with oLC3371. This construct can be liberated by digestion with SacII and
transformed into C. albicans.
pLC858: This plasmid is based on pLC833 but harbors additional
phosphodeﬁcient mutations in CAS5 (S462A/S464A). This mutation was
introduced by site-directed mutagenesis with primers oLC3418 and oLC3419. The
plasmid was sequence veriﬁed with oLC3371. This construct can be liberated by
digestion with SacII and transformed into C. albicans.
Culturing conditions. All cultures were grown shaking at 200 rpm. To assess the
effects of caspofungin and calcoﬂuor white treatment on the expression of Cas5
and Cas5-dependent of transcripts, overnight cultures were diluted to OD600 of
0.15 in YPD for 3 h, and either untreated or treated with 125 ng/ml of caspofungin
or 100 µg/ml of calcoﬂuor white for 1 or 2 h, as speciﬁed. To deplete GLC7, strains
were grown overnight at 30 °C in YPD. Stationary phase cultures were split,
adjusted to an OD600 of 0.15, at which point one culture was treated with 0.02 µg/
ml of doxycycline, whereas the other was left untreated. Cells were grown for 16 h
and were split again, adjusted to an OD600 of 0.15 and grown for 3 h. One culture
was subsequently treated with 125 ng/ml of caspofungin for 1 or 2 h as speciﬁed,
whereas the other was left untreated.
ChIP-Seq data generation and analysis. Chromatin preparation and immuno-
precipitation against PolII using 2 µl of 8WG16 antibody were performed as
described previously65. Multiplex sequencing libraries were constructed according
to Wong et al.66 ChIP-Seq libraries were assessed by Bioanalyzer DNA High
Sensitivity Assay and quantiﬁed using real-time PCR before sequencing on the
Illumina HiSeq2500 platform. Raw reads were mapped to the C. albicans reference
genome. Mapped reads on gene bodies were counted, normalized to total number
of mapped reads and expressed as “Normalized PolII ChIP-Seq signal”. Differen-
tially bound genes are deﬁned by greater than 1.5-fold difference in PolII ChIP-Seq
signals between any two conditions analyzed. Non-expressed genes or lowly
expressed genes (e.g., genes with PolII ChIP-Seq signals lower than 10) under both
conditions analyzed were removed from downstream analysis. Pathway analysis
was carried out using the GO program on the Candida Genome Database (http://
www.candidagenome.org/cgi-bin/GO/goTermFinder) and the KEGG mapper
(http://www.genome.jp/kegg/tool/map_pathway2.html).
Minimum inhibitory concentration assay. Antifungal susceptibility was measured
in ﬂat bottom, 96-well microtitre plates (Sarstedt #83.3924) using a broth micro-
dilution protocol described in ref. 67. In brief, minimum inhibitory concentration
(MIC) assays were set up in twofold serial dilutions of caspofungin or calcoﬂuor
white in a ﬁnal volume of 200 µl per well. Caspofungin gradients were diluted
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either from 125 ng/ml down to 0.12 ng/ml or 2000 to 3.9 ng/ml. Calcoﬂuor white
gradients were diluted from 250 µg/ml down to 0.24 µg/ml. Where applicable,
doxycycline was added to a ﬁnal concentration of 0.1 µg/ml. Cell densities of
overnight cultures were determined and dilutions were prepared such that ~103
cells were inoculated into each well. Plates were incubated in the dark at 30 °C for
48 h, at which point the absorbance was determined at 600 nm using a spectro-
photometer (Molecular Devices) and corrected for background from the corre-
sponding medium. Each strain was tested in duplicate in three biological replicates.
MIC data was quantitatively displayed with color using the program Java TreeView
1.1.3 (http://jtreeview.sourceforge.net).
Flow cytometry analysis. Yeast strains were cultured overnight in 4 ml YPD at
30 °C. Cells were subcultured for 4–5 h and isolated during exponential growth.
Overall, 400 μl of cells were pelleted and ﬁxed overnight in 70% ethanol at 4 °C.
The ﬁxed cells were washed twice with 1 ml of sodium citrate (50 mM) and
resuspended in 500 μl sodium citrate and 12 μl of RNaseA (25 mg/ml). The cells
were incubated at 37 °C for 4 h. Then 17 μl of propidium iodide was added to the
RNase-treated cells and incubated overnight at 37°C. The cells were vortexed and
sonicated for 5 s at level 15 of the Sonic Desmembrator (Fisher Scientiﬁc), and
ﬁltered immediately before analysis using a BD Falcon tube with a 35 μm nylon
mesh cap (Cat. No. 352235). Ploidy was determined using a Yetti ﬂow cytometer,
and 50,000–100,000 cells were analyzed per strain.
Co-immunoprecipitation. Cultures were grown to mid-exponential phase and
harvested by centrifugation at 3000 rpm for 5 min. The cells were washed with
sterile H2O and resuspended in 1 mL of lysis buffer (20 mM Tris pH 7.5, 100 mM
KCl, 5 mM MgCl, and 20% glycerol), with one protease inhibitor cocktail per 50 ml
(complete, EDTA-free tablet, Roche Diagnostics, Indianapolis, IN, USA) and 1 mM
PMSF (EMD Chemicals, Gibbstown, NJ, USA). Cells were lysed by bead beating
twice for 4 min with 7 min on ice between cycles. Lysates were recovered by
piercing a hole in the bottom of each tube, placing each tube in a 14 ml conical
tube, and centrifuging at 1300×g for three 5-min cycles, recovering the supernatant
after each stage. The combined lysate was cleared by centrifugation at 21,000×g for
10 min at 4 °C. The protein concentrations were determined using the Bradford
assay68. Anti-HA immunoprecipitations were done using Pierce HA-Tag IP/Co-IP
kit (Thermo-Fisher Scientiﬁc, PI23610), as per manufacturer’s instructions.
Western blot analysis. Protein was extracted by pelleting cells at OD600 of 0.8,
with the pellet being resuspended in 2× sample buffer (one-third volume of 6×
sample buffer containing 0.35 M Tris-HCl, 10% (w/w) SDS, 36% glycerol, 5% β-
mercaptoethanol, and 0.012% bromophenol blue). The samples were boiled for 5
min at 95 °C. The cell debris was pelleted and the supernatant was separated on a
6% SDS-PAGE gel to observe changes in Cas5 mobility. Separated proteins were
electrotransferred to PVDF membrane (Bio-Rad Laboratories) and blocked with
5% skim milk in phosphate-buffered saline (PBS) with 0.2% Tween-20 at room
temperature for 1 h. Blots were hybridized with antibody against the HA epitope
(1:5000 dilution; Roche Diagnostics), p44/42 (1:2000, Cell Signaling), PSTAIRE
(1:5000, Santa Cruz Biotechnology), TAP (1:5000; Open Biosystems), Hsp90
(1:10,000; generously provided by Brian Larsen, Des Moines University) or α-β-
actin (1:5000; Santa Cruz, sc-47778) overnight at 4 °C. Blots were washed with PBS
with 0.1% Tween-20 and subsequently hybridized with FITC-conjugated secondary
antibody diluted 1:5000 in the block solution for 45 min at room temperature.
Signals were detected using an ECL western blotting kit as per the manufacturer’s
instructions (Pierce).
Two-dimensional western blot analysis. C. albicans Cas5-HA cells were har-
vested from log phase cultures in YPD (+/−caspofungin) with lysis buffer (150 mM
NaCl, 50 mM Tris-HCl pH 7, 15 mM EDTA, 1% Triton 100-X, 10% glycerol) plus
phosphatase inhibitors (Sigma, P5726 and P0044) and protease inhibitors (Roche
complete Mini Protease Inhibitor Cocktail Tablets 04693124001) using glass beads
and bead beating 10 × 20 s with 1 min ice in between. Cell extracts were pre-
cipitated with methanol–chloroform and resuspended in rehydration buffer (Bio-
Rad Cat#163-2105). Approximately 30 μg protein was loaded onto 7 cm IPG strips
(pH 3-10, Bio-Rad Cat#163-2000) and resolved using Bio-Rad Protean i12 IEF
System. The IPG strips were then resolved using 10% SDS-PAGE gels
and processed for western blotting following the procedures described above for
one-dimensional western blot analysis.
Quantitative RT-PCR. To prepare samples for RNA extraction, 10 ml of sub-
culture was harvested by centrifugation at 1300×g for 5 min. The pellet was ﬂash-
frozen and stored at −80 °C overnight. RNA was isolated using the QIAGEN
RNeasy kit and cDNA was generated using the AfﬁnityScript cDNA synthesis kit
(Stratagene). qRT-PCR was carried out using the Fast SYBR Green Master Mix
(Thermo-Fisher Scientiﬁc) in 384-well plates with the following cycle conditions:
95 °C for 10 min, repeat 95 °C for 10 s, 60 °C for 30 s for 40 cycles. The melt curve
was completed with the following cycle conditions: 95 °C for 10 s and 65 °C for 5 s
with an increase of 0.5 °C per cycle up to 95 °C. All reactions were done in tri-
plicate. Data were analyzed in the Bio-Rad CFX manager 3.1. Data was plotted
using GraphPad Prism.
Afﬁnity puriﬁcation and liquid chromatography-tandem mass spectrometry
analysis. For afﬁnity puriﬁcation (AP) and liquid chromatography-tandem mass
spectrometry (LC-MS/MS) analysis, clariﬁed whole-cell lysates (10 mg protein per
sample) were extracted with immobilized anti-HA beads (Pierce HA-Tag IP/Co-IP
kit, Thermo-Fisher Scientiﬁc, PI23610). After a 3-h incubation, the beads were
washed three times with lysis buffer and twice with HPLC water. The proteins
bound on beads were eluted with 150 µl of 0.15% triﬂuoroacetic acid (TFA),
neutralized with 100 mM NH4HCO3, and digested with trypsin. The tryptic pep-
tides were puriﬁed by 200 µl C18 stage tips (Thermo Scientiﬁc, Rockford, IL, USA)
and analyzed by Q-Exactive LC-MS/MS69. The tryptic peptides from anti-HA IP
complexes were separated on a 50-cm Easy-Spray column with a 75-µm inner
diameter packed with 2 µm C18 resin (Thermo Scientiﬁc, Odense, Denmark). The
peptides were eluted over 120 min (250 nl/min) using a 0 to 40% acetonitrile
gradient in 0.1% formic acid with an EASY nLC 1000 chromatography system
operating at 50 °C (Thermo-Fisher Scientiﬁc). The LC was coupled to a Q-Exactive
mass spectrometer70 by using a nano-ESI source (Thermo-Fisher Scientiﬁc). Mass
spectra were acquired in a data-dependent mode with an automatic switch between
a full scan and up to 10 data-dependent MS/MS scans. Target value for the full scan
MS spectra was 1e6 with a maximum injection time of 120 ms and a resolution of
70,000 at m/z 400. The ion target value for MS/MS was set to 1,000,000 with a
maximum injection time of 120 ms and a resolution of 17,500 at m/z 400. The ﬁrst
mass for the MS/MS was set to 140m/z and the normalized collision energy was set
to 27. Unassigned, as well as charge states 1 and >5 were ignored for MS/MS
selection. Repeat sequencing of peptides was kept to a minimum by dynamic
exclusion of sequenced peptides for 12 s71.
Acquired raw ﬁles were analyzed by using MaxQuant software72 (version
1.3.0.5) for quantiﬁcation, and X! Tandem (The GPM, thegpm.org; version
CYCLONE; 2010.12.01.1) and Scaffold (version Scaffold_3.4.3, Proteome Software,
Portland, OR, USA) for further validation. The default search parameters were
used as described by Deeb et al.71. The search included cysteine
carbamidomethylation as a ﬁxed modiﬁcation, as well as N-terminal acetylation,
methionine oxidation, and phospho-serine, -threonine, and -tyrosine as variable
modiﬁcations. Localization probability for phosphorylation sites was required to
exceed 75%. The second peptide identiﬁcation option in Andromeda was enabled.
For statistical evaluation of the data obtained, the posterior error probability and
false discovery rate were used. The false discovery rate was determined by searching
a reverse database. A false discovery rate of 0.01 for proteins and peptides was
permitted. Two miscleavages were allowed, and a minimum of seven amino acids
per identiﬁed peptide were required. Peptide identiﬁcation was based on a search
with an initial mass deviation of the precursor ion of up to 6 ppm, and the allowed
fragment mass deviation was set to 20 ppm. To match identiﬁcations across
different replicates and adjacent fractions, the “match between runs” option in
MaxQuant was enabled within a time window of 2 min.
Microscopic analysis. Cultures were grown to mid-exponential phase and 1 ml of
the cells was centrifuged at 14,000 rpm for 1 min. The supernatant was removed
and the cells were washed with PBS. To stain for chitin, calcoﬂuor white was added
to a ﬁnal concentration of 1 µg/ml in a ﬁnal volume of 100 µl. The cells were
incubated in the dark for 15 min and were gently vortexted every 3–4 min. Cells
were washed with PBS and 2 µl of the cells were deposited on a cover slide. To stain
for nuclei, the cells were heat ﬁxed on the slide for 1 min at 75 °C and 0.5 µl of 1
mg/ml DAPI was added. All imaging was performed on a Zeiss Imager M1 upright
microscope and AxioCam Mrm with AxioVision 4.7 software. For ﬂuorescence
microscopy, an X-cite series 120 light source with ET green ﬂuorescent protein
(GFP), 4′,6-diamidino-2-phenylindole (DAPI) hybrid, and ET HQ tetra-
methylrhodamine isothiocyanate (TRITC)/DsRED ﬁlter sets from Chroma Tech-
nology (Bellows Falls, VT, USA) was used. Calcoﬂuor white and DAPI were viewed
under the DAPI hybrid ﬁlter and HA-tagged Cas5 was viewed under the Texas Red
ﬁlter. To facilitate nuclei counting, 12 Z stacks were taken for each image, where
each slice is 0.3 μm.
Indirect immunoﬂuorescence microscopy. To obtain cells for immuno-
ﬂuorescence, 5–10 ml of subculture was grown to mid-exponential phase and ﬁxed
with 5% formaldehyde for 3–4 h at 30 °C. Cells were harvested at 1300×g for 5 min
and washed once with 5 ml S-Buffer (50 mM HEPES pH 7.5, 1.2 M Sorbitol) before
being resuspended in 1 ml S-Buffer. To induce spheroplast formation, 10 µl of 1 M
DTT, 30 µl of glusulase, and 40 µl of 2.5 mg/ml zymolase were added to the cells
and the mix was incubated for 30 min at 37 °C. The extent of spheroplasting was
monitored under the microscope. The poly lysine (Lys) coated slides were prepared
by adding 15 µl of 0.1% poly Lys per slide well and set aside for 15 min. Wells were
washed three times with PBS. The ﬁxed cells were centrifuged for 1 min at 5000
rpm and gently resuspended in 1 ml S-buffer. Following the addition of 0.1%
Triton X-100, the mix was incubated for 5 min on rocker. The cells were cen-
trifuged for 1 min at 5000 rpm and resuspended in 1 ml S-Buffer. To adhere the
cells, 20 µl of cell suspension was added on to poly Lys-coated well and incubated it
for 15 min. The cells were washed three times with PBS-T and the wells were
blocked with 20 µl PBS/BSA for 5–10 min. Anti-HA antibody diluted 1:300 in 20 µl
was added and incubated for 3–4 h or overnight in a humid chamber. The cells
were washed four times in PBS-T. Anti-mouse IgG-Cy3 diluted 1:500 in PBS-T was
added to the wells and incubated for 1–2 h. The cells were washed four times with
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PBS-T and once with only PBS. Overall, 20 µl of 1 mg/ml DAPI diluted 1:1000 in
PBS was added to the wells and incubated for 5 min. The cells were washed four
times with PBS. The cells were left to dry in the dark for 30 min at room tem-
perature. Mounting medium was added and cells were viewed under the
microscope.
Data availability. The ChIP-seq data have been deposited in the NCBI Sequence
Read Archive with accession code SRP106998. The authors declare that all other
data supporting the ﬁndings of the study are available in this article and its Sup-
plementary Information ﬁles, or from the corresponding author upon request.
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